Chemically modified cytokines

Details Chemically modified cytokines Chemically modified cytokines

2007-04-24

2007-04-24

Mertz, Prema (Department: 1646)

Drug, bio-affecting and body treating compositions

Lymphokine

C424S085200, C424S085400, C530S402000, C530S403000, C530S404000, C530S405000, C530S406000, C530S351000

Reexamination Certificate

active

11084175

ABSTRACT:
The invention concerns a derivative of viral regulatory protein or a fragment of viral regulatory protein or of the alpha interferon or a fragment of alpha interferon, which is carboxymethylated, a method for preparing, use of the resulting product in a method of treatment for the human or animal body, a pharmaceutical composition and a vaccine containing as active principle, at least one of the carboxymethylated proteins or fragments.

REFERENCES:
patent: 4414147 (1983-11-01), Klibanov et al.
patent: 2 677 654 (1991-06-01), None
patent: 2 773 156 (1997-12-01), None
patent: WO 94/21288 (1994-09-01), None
patent: WO 94/21288 (1994-09-01), None
Tsunoda et al., Japanese Journal of Clinical Medicine, 56(3)573-578 (Mar. 1998).

Affiliated with

Also associated with

Rating

Chemically modified cytokines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chemically modified cytokines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemically modified cytokines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3756824